info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142531 |
| CAS No | NA |
| Mol.F. | C28H33N3O3 |
| Mol.Wt. | 459.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142532 |
| CAS No | NA |
| Mol.F. | C29H34N4O6S |
| Mol.Wt. | 566.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142533 |
| CAS No | NA |
| Mol.F. | C26H28N2O3 |
| Mol.Wt. | 416.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142534 |
| CAS No | NA |
| Mol.F. | C9H11BrN2O2 |
| Mol.Wt. | 259.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142535 |
| CAS No | NA |
| Mol.F. | C27H28N2O5 |
| Mol.Wt. | 460.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142536 |
| CAS No | NA |
| Mol.F. | C26H26N2O5 |
| Mol.Wt. | 446.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142537 |
| CAS No | NA |
| Mol.F. | C20H24N2O5S |
| Mol.Wt. | 404.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142538 |
| CAS No | NA |
| Mol.F. | C28H30N2O7S |
| Mol.Wt. | 538.6 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142539 |
| CAS No | NA |
| Mol.F. | C27H28N2O7S |
| Mol.Wt. | 524.6 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142540 |
| CAS No | NA |
| Mol.F. | C19H22N2O3 |
| Mol.Wt. | 326.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142541 |
| CAS No | NA |
| Mol.F. | C29H33N3O6S |
| Mol.Wt. | 551.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142542 |
| CAS No | NA |
| Mol.F. | C21H25ClN2O2 |
| Mol.Wt. | g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142543 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142544 |
| CAS No | NA |
| Mol.F. | C30H35N3O4 |
| Mol.Wt. | 501.63 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142545 |
| CAS No | NA |
| Mol.F. | C23H26F2N8O6S |
| Mol.Wt. | 580.57 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142546 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mol |
| INV STATUS | UNDER SYNTHESIS |
